These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 30200836

  • 1. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Belhaj Nefissi R, Doggui R, Ouali F, Messaoud T, Gritli N.
    Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

  • 3. Thrombophilic Mutations Among Patients with Sickle Cell Disease.
    Nefissi RB, Ouali F, Massaoud T, Gritli N.
    Clin Lab; 2017 Nov 01; 63(11):1815-1818. PubMed ID: 29226645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2005 Jun 01; 19(3):189-96. PubMed ID: 16082606
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
    Pandey SK, Meena A, Kishor K, Mishra RM, Pandey S, Saxena R.
    Clin Appl Thromb Hemost; 2012 Jun 01; 18(3):320-3. PubMed ID: 22084413
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
    Rahimi Z, Ghaderi M, Nagel RL, Muniz A.
    J Thromb Thrombolysis; 2008 Dec 01; 26(3):229-33. PubMed ID: 17982733
    [Abstract] [Full Text] [Related]

  • 12. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
    Borsi E, Potre O, Ionita I, Samfireag M, Secosan C, Potre C.
    Medicina (Kaunas); 2024 Mar 22; 60(4):. PubMed ID: 38674167
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.
    Blood Coagul Fibrinolysis; 2009 Dec 22; 20(8):675-8. PubMed ID: 19710606
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Dec 22; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 15. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May 22; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

  • 16. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
    Moreira Neto F, Lourenço DM, Noguti MA, Morelli VM, Gil IC, Beltrão AC, Figueiredo MS.
    Braz J Med Biol Res; 2006 Oct 22; 39(10):1291-5. PubMed ID: 16906320
    [Abstract] [Full Text] [Related]

  • 17. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2004 Jun 22; 17(3):199-205. PubMed ID: 15353918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.